Dr. Darla Liles, Hematologist/Oncologist at East Carolina University and sickle cell patient Majara (who participated in the SUSTAIN clinical trial) discuss the unique challenges facing sickle cell patients, including the impact of sickle cell pain crises. They’ll also discuss the latest FDA-approved treatment, Adakveo® (crizanlizumab-tmca) for use in people 16 years of age and older, and how it may help reduce those painful episodes and potentially life-threatening complications.
Dr. Darla Liles is an oncologist in Greenville, North Carolina practicing in the Hematology-Oncology Division at East Carolina University. Liles was an investigator on the SUSTAIN clinical trial evaluating crizanlizumab for the reduction of the frequency of vaso-occlusive crises (VOCs). She received her medical degree from University of Missouri – Kansas City School of Medicine and has been in practice for more than 20 years.